YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

YIHCF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$1,403,777$1,674,413$923,543$1,131,121
Short-Term Investments$3,839$0$290,000$0
Receivables$2,155,554$2,092,233$1,005,817$479,041
Inventory$645,929$409,050$315,027$279,696
Other Curr. Assets$824,304$1,877,360$2,479,633$167,518
Total Curr. Assets$5,033,403$6,053,056$5,014,020$2,057,376
Property Plant & Equip (Net)$4,607,514$3,740,424$3,518,765$3,216,555
Goodwill$0$0$0$75,896
Intangibles$2,509,760$1,470,229$1,782,383$2,070,644
Long-Term Investments$38,691$32,158$5,160,539$1,789,621
Tax Assets$236,008$0$140,609$65,318
Other NC Assets$3,839$1,448,462-$5,301,148-$65,318
Total NC Assets$7,395,812$6,691,273$5,301,148$7,152,716
Other Assets$0$0$1,574,632$1,331,489
Total Assets$12,429,215$12,744,329$11,889,800$10,541,581
Liabilities
Payables$177,286$200,088$167,387$115,322
Short-Term Debt$1,335,029$2,319,877$3,130,306$48,477
Tax Payable$92,934$297,343$160,598$250,755
Deferred Revenue$0$0-$3,130,306-$48,477
Other Curr. Liab.$1,235,282$1,514,912$1,482,490$823,510
Total Curr. Liab.$2,840,531$4,332,220$4,940,781$1,238,064
LT Debt$899,806$289,451$691,529$3,145,025
Deferred Rev, NC$180,682$0$187,489$137,730
Deferred Tax Liab, NC$0$0$504,040$3,007,295
Other NC Liab.$0$187,145$0$0
Total NC Liab.$1,080,488$476,596$691,529$3,145,025
Other Liabilities$0$0$187,489$137,730
Cap. Leases$313,864$189,892$0$0
Total Liabilities$3,921,019$4,808,816$5,819,799$4,520,819
Equity
Pref Stock$0$439,987$0$0
Common Stock$879,968$879,968$879,968$879,968
Retained Earnings$4,429,856$3,947,144$2,394,507$2,317,904
AOCI$0$2,668,414$2,610,409$2,610,409
Other Equity$3,198,372$0$0$0
Total Equity$8,508,196$7,935,513$5,884,884$5,808,281
Supplemental Information
Minority Interest$0$0$185,117$212,481
Total Liab. & Tot. Equity$12,429,215$12,744,329$11,889,800$10,541,581
Net Debt$831,058$934,915$2,898,292$2,062,381